EPIX News and Press, ESSA Pharma Inc. From 08/04/22

ESSA Pharma press release ( NASDAQ: EPIX ): FQ3 GAAP EPS of -$0.20 (vs. -$0.21 Y/Y). At June 30, 2022, the Company had available cash reserves and short-term investments of $174.6 million. For further details see: ESSA Pharma GAAP EPS of -$0.20

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2022 PR Newswire SOUTH SAN FRANCISCO, California and VANCOUVER, Canada , Aug. 4, 2022 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Com...

Essa Pharma ( EPIX ) is trading 6% higher after its 10% owner Growth Biotech bought 300,000 common shares at $3.1558 for $947K. Growth Biotech now owns 5,879,583 common shares. For further details see: Essa Pharma trades 6% higher after 10% owner buys more shares

ESSA Pharma Insiders Establish Automatic Securities Disposition Plans Canada NewsWire SOUTH SAN FRANCISCO, California and VANCOUVER, Canada , , June 30, 2022 /CNW/ - ESSA Pharma Inc. (Nasdaq: EPIX) ("ESSA" or the "Company"), a clinical-stage pharm...

ESSA Pharma Presents Clinical Update on EPI-7386 Monotherapy and Combination Therapy Clinical Development Canada NewsWire EPI-7386 was safe and well-tolerated at all dose levels and schedules tested with plasma target concentrations achieved and clinically important ef...

ESSA Pharma to Present at 2022 Jefferies Healthcare Conference Canada NewsWire SOUTH SAN FRANCISCO, California and VANCOUVER, Canada , June 2, 2022 /CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutica...

ESSA Pharma press release (NASDAQ:EPIX): Q2 GAAP EPS of -$0.25. At March 31, 2022, the Company had available cash reserves and short-term investments of $181.0 million reflecting the gross proceeds of the February 2021 financing of approximately $150.0 million and July 2020 financing of $48.9...

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2022 Canada NewsWire SOUTH SAN FRANCISCO, Calif. and VANCOUVER, Canada , May 10, 2022 /CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NA...

ESSA Pharma to Present at the 2022 Bloom Burton & Co. Healthcare Investor Conference ESSA Pharma to Present at the 2022 Bloom Burton & Co. Healthcare Investor Conference Canada NewsWire SOUTH SAN FRANCISCO, California and VANCOUVER, Canada , A...

The following slide deck was published by ESSA Pharma Inc. in conjunction with this event. For further details see: ESSA Pharma (EPIX) Presents At Oppenheimer Healthcare Conference